Wilmington, Delaware — The Innovation Space™ today announced that 10 startups have been selected to join its Fall 2025 Science Inc.™ | Life Sciences Accelerator the first sector-specific cohort in the program’s five-year history. This 14-week virtual accelerator is designed to help early-stage science startups advance complex technologies and prepare for their next funding round. The fall curriculum is curated for founders in the life sciences and related biotech fields, pairing expert coaching from Entrepreneurs-in-Residence subject matter experts, and investors. Science Inc. participants will work toward critical milestones that strengthen their business models, refine their fundraising strategies, and accelerate growth.
“This Science Inc. Life Sciences cohort is truly impressive, comprising companies driving innovation across a broad spectrum of significant opportunities and needs,” said Bill Provine, founder and CEO of Innovation Space. “These startups are developing novel therapeutics and advanced diagnostics to cure and detect cancer early, pioneering technologies that improve patient care, strengthening the viability of the world’s food supply, and driving health outcomes.”
Companies participating in the Fall 2025 cohort:
Ajaya Bio is developing bispecific antibodies that eliminate disease-causing immune cells without broad immunosuppression.
Antelope Surgical Solutions, Inc. is advancing the first PSMA-targeted fluorescent and radioligand agent for real-time cancer surgery, imaging, and therapy.
APASOMICS is developing precision drug delivery systems for bone treatments, targeting hard-to-reach tissues with controlled, prolonged release, enhancing efficacy and minimizing systemic side effects.
ClearVision Therapeutics, Inc. is developing the 1st RNA cure to stop genetic corneal diseases, improve corneal function and decrease dependence on transplants.
Ex-Amplify Therapeutics is building a “once and done” gene therapy for migraine pain that targets an unexplored calcium channel, with AI/ML-backed gene therapy cargo design enabling activation under migraine trigger.
HeraNano Therapeutics is developing safe, effective, and accessible nanoparticle drug delivery systems to address critical unmet needs in women’s health.
Larada Therapeutics, Inc. is advancing treatment for rare ocular diseases that currently have no approved therapies.
LisenID is utilizing epigenetic imprinting biomarkers and AI to eliminate indeterminate tumors and enable providers to make confident, doubt free diagnoses.
Livestock Labs is engineering high-performance animal cells that enable food companies to grow real meat — without the animal — faster, cheaper, and at scale.
Riboway Therapeutics is developing RNA-targeted therapeutics to make every protein druggable, enabling precise control of protein expression and function through leveraging AI to decode RNA biology.
Including the current cohort, Science Inc. has now supported 88 startups from 20 states and five countries. Alumni have gone on to secure follow-on funding, scale operations, and bring new innovations to market.
The Science Inc. accelerator runs twice annually, with fall cohorts focused on life sciences and spring cohorts dedicated to clean technology and advanced materials. Applications are highly competitive, drawing startups nationwide and beyond, with the program designed to help selected companies sharpen their strategies and position themselves for successful fundraising.
###
About The Innovation Space:
The Innovation Space™ is a nonprofit innovation ecosystem and the virtual and physical home for science-driven startups. Located on the historic Experimental Station campus in Wilmington, Delaware, it offers 130,000 ft2 of state-of-the-art lab and office space, access to cutting edge equipment, and a suite of strategic entrepreneurship programs and funding opportunities. With a mission to transform science and technology startups into industry-leading companies, The Innovation Space supports founders in life sciences, clean tech, and advanced materials with the resources, capital, and community they need to grow and scale.
Learn more at innovationspace.org, and subscribe to our quarterly newsletter for updates on programs, funding opportunities, and community milestones: innovationspace.org/signup.